Insider Trading & Ownership of Rick E. Winningham
-
Location
-
South San Francisco, CA
-
Summary
-
The estimated net worth of Rick E. Winningham is at least $34,670,095 dollars as of 03 Apr 2026. Rick E. Winningham is the CHIEF EXECUTIVE OFFICER, Director of Theravance Biopharma, Inc. and owns shares of Theravance Biopharma, Inc. (TBPH) stock worth about $33.06M. Rick E. Winningham is the Director of Jazz Pharmaceuticals plc and owns shares of Jazz Pharmaceuticals plc (JAZZ) stock worth about $1.61M.
-
Signature
-
/s/ Brett A Grimaud, Attorney-in-Fact
Follow Filing Activity
Follow Rick E. Winningham and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Quick Takeaways
- Rick E. Winningham has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $34,670,095.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: Theravance Biopharma, Inc. ($33,061,710).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Rick E. Winningham
Insider Transactions Reported by Rick E. Winningham:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.